Table 2 Analysis of association between expression of YB1 protein and clinicopathological features of NPC.
From: YB1 associates with oncogenetic roles and poor prognosis in nasopharyngeal carcinoma
Clinicopathological features | YB1 | ||
|---|---|---|---|
P (%) | N (%) | P value | |
Gender | Â | Â | 0.434 |
Male (n = 302) | 122 (29.8) | 180 (43.9) |  |
Female (n = 108) | 39 (9.5) | 69 (16.8) |  |
Age | Â | Â | 0.760 |
 < 40 (n = 86) | 35 (8.5) | 51 (12.4) |  |
 ≥ 40 (n = 324) | 126 (30.7) | 198 (48.4) |  |
Clinical stages | Â | Â | *0.014 |
I and II (n = 117) | 35 (8.5) | 82 (20.0) |  |
III and IV (n = 293) | 126 (30.7) | 167 (40.8) |  |
LN status | Â | Â | 0.355 |
No LNM (n = 107) | 38 (9.3) | 69 (16.8) |  |
LNM (n = 303) | 123 (30) | 180 (43.9) |  |
Histological type | Â | Â | 0.931 |
UDNPC (n = 384) | 151 (36.8) | 233 (56.8) |  |
DNPC (n = 26) | 10 (2.4) | 16 (4.0) |  |
